|
Squire Sanders is pleased to sponsor and participate in the second annual Drug Development Latin America: Effectively Planning and Implementing Clinical Research and Trials conference on March 10-11 in Philadelphia, presented by the Cambridge Healthtech Institute (CHI) as part of the BioPharma Strategy Series.
Squire Sanders partner Maureen Bennett, chair of the firm’s global Life Sciences Practice Group, will lead the “Emerging Jurisdictions in Latin America” discussion at 9:15 on Thursday, March 11.
Topics include:
- Ethical issues in informed consent
- Continuing access to investigational medicines
- Investigator and institution payment issues
- Recent suspension of clinical trials in Costa Rica
As the globalization of R&D into emerging regions continues and R&D spending grows in Asia, Latin America and the Commonwealth of Independent States (CIS), many factors come into play: the attractiveness of commercial markets, more favorable economics including lower relative costs and greater speed, access to highly skilled professional labor and a large pool of patients. Consequently, pharmaceutical and biotechnology companies are seeing rapid growth in the volume of their clinical research, development and clinical trials in Latin America. However, this region presents specific challenges that must be anticipated and managed.
For more information and to register, visit the CHI website.
|